Loading...
Market
What will be the amount of Aqemia's next funding round by end of 2025?
3
Resolution / Starting Odds
Less than $20 million • 25%
$20 million to $50 million • 25%
$51 million to $100 million • 25%
More than $100 million • 25%
Official announcements from Aqemia or financial news reports
Story
Aqemia Secures $38 Million Funding, Hits $100 Million Milestone for Drug Discovery Expansion in London
Dec 10, 2024, 11:17 AM
Aqemia, a Paris-based start-up focused on drug discovery, has successfully raised $38 million in a funding round led by Cathay Innovation. This new funding adds to the company's previous €30 million raised in January 2024. The capital will enable Aqemia to advance its clinical trials and expand its operations globally, beginning with a new office in London, UK. The company utilizes a unique approach that combines theoretical physics and generative AI to enhance drug discovery processes, marking a significant step in the integration of advanced technologies in pharmaceuticals.
View original story
Similar markets
$300 million to $500 million • 25%
Over $1 billion • 25%
$500 million to $1 billion • 25%
Less than $300 million • 25%
Less than 50 • 25%
150 or more • 25%
50 to 99 • 25%
100 to 149 • 25%
Less than $50 billion • 25%
$60 billion to $70 billion • 25%
More than $70 billion • 25%
$50 billion to $60 billion • 25%
No funding raised • 25%
More than $2 billion • 25%
$1.5 billion to $2 billion • 25%
Less than $1.5 billion • 25%
$2 billion or more • 25%
Less than $1 billion • 25%
$1-$1.49 billion • 25%
$1.5-$1.99 billion • 25%
Series C • 25%
Acquisition • 25%
No new funding • 25%
Series D • 25%
$3 billion to $4 billion • 25%
More than $5 billion • 25%
Less than $3 billion • 25%
$4 billion to $5 billion • 25%
$50-$59 billion • 25%
$40-$49 billion • 25%
Below $40 billion • 25%
$60 billion • 25%
Below $8 billion • 25%
Above $12 billion • 25%
$10 billion to $12 billion • 25%
$8 billion to $10 billion • 25%
Other existing investor • 25%
A new investor • 25%
Kleiner Perkins • 25%
General Catalyst • 25%